These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 278414)

  • 41. Phase II clinical evaluation of AZQ in metastatic breast cancer.
    Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anticancer chemotherapy with evaluation of combined treatments].
    Saito T
    Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antitumor action of new 2,4-diethyleneimino-6-amino-sym.-triazina derivatives].
    Maliugina LL; Pol'kina RI; Kraĭz BO; Remizov AL
    Vopr Onkol; 1977; 23(12):70-5. PubMed ID: 602082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute erythromyelosis. Study of a clinical case].
    Tiszai A; Krizsa F; Rák K
    Munch Med Wochenschr; 1967 Feb; 108(7):357-61. PubMed ID: 5233449
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Griffin JP; Newman RA; McCormack JJ; Krakoff IH
    Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The functional activity of the natural killers during the experimental treatment of hemoblastoses].
    Gashchuk AP; Evtukh VP; Zverkova AS
    Vrach Delo; 1990 Nov; (11):64-6. PubMed ID: 2098989
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of the Soviet preparations, fotrin and imifos, in erythremia].
    Petrov KIa; Buglaev AP
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):14-6. PubMed ID: 7413620
    [No Abstract]   [Full Text] [Related]  

  • 48. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Kamen BA; Holcenberg JS; Siegel SE
    Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
    [No Abstract]   [Full Text] [Related]  

  • 49. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II trial of diaziquone in patients with colon cancer.
    Neidhart JA; Erlichman C; Robert F; Velez-Garcia E; Bender JF; Grillo-López J
    Cancer Treat Rep; 1985 Feb; 69(2):215-7. PubMed ID: 3882229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinostatic action of 2-cyanaziridines against a sarcoma in rats.
    Bicker U; Fuhse P
    Exp Pathol (Jena); 1975; 10(5-6):279-84. PubMed ID: 1233288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
    Carey RW; Comis RL; Anbar D; Kennedy BJ; Capizzi RL; Shulman P; Booth BW; Green M; Raich PC
    Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
    [No Abstract]   [Full Text] [Related]  

  • 53. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.
    Vinciguerra V; Anderson K; McIntyre OR
    Cancer Treat Rep; 1985 Mar; 69(3):331-2. PubMed ID: 3884154
    [No Abstract]   [Full Text] [Related]  

  • 55. [Extremely undifferentiated acute erythremic myelosis].
    Drescher J; Leder LD
    Z Kinderheilkd; 1970; 108(2):117-37. PubMed ID: 5281035
    [No Abstract]   [Full Text] [Related]  

  • 56. Response of human tumours 'in vitro' to CB-1954 (5-aziridinyl-2, 4-dinitrobenzamide).
    Bhat AV; Rao KV; Bapat CV
    Indian J Cancer; 1977 Jun; 14(2):132-5. PubMed ID: 914303
    [No Abstract]   [Full Text] [Related]  

  • 57. [The theoretical bases of chemotherapy of hemoblastosis].
    Baserga A
    Minerva Med; 1966 Mar; 57(25):1082-6. PubMed ID: 5219053
    [No Abstract]   [Full Text] [Related]  

  • 58. [Results of the studies of ethyleneiminotriazines].
    Ivin BA; Kraĭz BO; Korsakov MV; Stukov AN; Sheĭman VP; Filov VA
    Vopr Onkol; 1990; 36(1):6-12. PubMed ID: 2407028
    [No Abstract]   [Full Text] [Related]  

  • 59. Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.
    Mulder NH; Meijers WH; van der Meulen JD; Sleijfer DT; Uges DR; de Vries EG; Postmus PE; van de Grampel JC; Willemse PH
    Cancer Treat Rep; 1987 Feb; 71(2):155-9. PubMed ID: 3026625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of cytostatic treatment on the initiation of plasma coagulation in patients with neoplastic diseases.
    Czestochowska E; Tymiński W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):574-9. PubMed ID: 6170552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.